Bharat Immunologicals & Biologicals Corporation Limited announced earnings results for the fourth quarter ended March 31, 2019. For the fourth quarter, the company announced total revenue was INR 726.971 million compared to INR 223.048 million a year ago. Net loss was INR 22.421 million compared to INR 13.060 million a year ago. Basic loss per share was INR 0.52 compared to INR 0.3 a year ago. For the full year, total revenue was INR 862.835 million compared to INR 361.925 million a year ago. Net loss was INR 55.568 million compared to INR 42.620 million a year ago. Basic loss per share was INR 1.29 compared to INR 0.99 a year ago.